Mucosal infection and immune responses to simian immunodeficiency virus

Mucosal Immunology, Two-Volume Set

Volumn , Issue , 2005, Pages 1179-1197

  Lehner, Thomas ^a   Bergmeier, Lesley Ann ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33746914593     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012491543-5/50070-X     Document Type: Chapter

References (227)

1. Abel K, Alegria-Hartman MJ, Zannato K, McChesney MB, Marthas ML, Miller CJ Anatomic site and Immune function correlate with relative cytokine mRNA expression levels in lymphoid tissues of normal rhesus macaques. Cytokine 2001, 16:191-204.
2. Afonso LCC, Scharton TM, Viera LQ, Wysocka M, Trincheieri G, Scott P The adjuvant effect of interleukin-12 in a vaccine against Leishmania major. Science 1994, 263:235-237.
3. Agace WW, Amara A, Roberts AI, Pablos JL, Thein S, Uguccioni MG, Li XY, Marsal J, Arenzana-Seisdedos F, Delaunauy T, Ebert EC, Moser B, Parker CM Constitutive expression of stromal derived factor -1 by mucosal epithelia and its role in HIV transmission and propagation. Curr. Biol. 2000, 10:325-328.
4. Albert J, Walhberg J, Leitner T, Escanilla D, Uhlen M Analysis of a rape case by direct sequencing of the human immunodeficiency virus type 1 pol and gag genes. J. Virol. 1994, 68:5918-5924.
5. Alcami A, Koszinowski UH Viral mechanisms of immune evasion. Immunol. Today 2000, 21:228-234.
6. Alfsen A, Iniguez P, Bouguyon E, Bomsel M Secretory IgA specific for a conserved epitope on gp41 envelope glycoprotein inhibits epithelial transcytosis of HIV-1. J. Immunol. 2001, 166:6257-6265.
7. Alkahatib G, Liao F, Berger EA, Farber JM, Peden KWC A new SIV co-receptor STRL33. Nature 1997, 388:238.
8. Amerongen HM, Weltzin R, Farnet CM, Michetti P, Haseltine WA, Neutra MR Transepithelial transport of HIV-1 by intestinal M cells: A mechanism for transmission of AIDS. J. Acquir. Immun. Defic. Syndr. 1991, 4:760-765.
9. Amamori I, Zhang J, Ferguson SSG, Bieniasz PD, Cullen BR, Caron MG Molecular mechanism of desensitization of the chemokine receptor CCR5: receptor signalling and internalisation are dissociable from its role as an HIV-1 co-receptor. EMBO J. 1997, 16:4606-4616.
10. Amara A, Gall SL, Schwartz O, Salamero J, Montes M, Loetscher P, Baggiolini M, Virelizier JL, Arenzana-Seisdedos F HIV coreceptor downregulation as antiviral principle: SDF-1 alpha-dependent internalisation of the chemokine receptor CXCR4 contributes to inhibition of HIV replication. J. Exp. Med. 1997, 186:139-146.
11. Ansari AA, Mayne AE, Sundstrom JB, Bostik P, Grimm B, Altman JD, Villinger F Administration of recombinant rhesus interleukin-12 during acute simian immunodeficiency virus (SIV). infection leads to decreased viral loads associated with prolonged survival in SIVmac251-infected rhesus macaques. J. Virol. 2002, 76:1731-1743.
12. Anton PA, Poles MA, Elliot J, Mao SH, McGowan I, Lenz HJ, Chen IS Sensitive and reproducible quantitation of mucosal HIV-1 RNA and DNA viral burden in patients with detectable and undetectable plasma viral HIV-1 RNA using endoscopic biopsies. J. Virol. Methods. 2001, 95:65-79.
13. Archibald DW, Witt DJ, Craven DE, Vogt MW, Hirsch MS, Essex M Antibodies to human immunodeficiency virus in cervical secretions from women at risk from AIDS. J. Infect. Dis. 1987, 156:240-241.
14. Armstrong JA, Horne R Follicular DCs and virus-like particles in AIDS-related lymphadenopathy. Lancet 1984, 1:370-372.
15. Arthos J, Deen K, Chaikin M, Fornwald J, Sathe G, Sattentau Q, Clapham P, Weiss R, McDougal J, Pietropaolo C, Axel R, Truneh A, Maddon P, Sweet R Identification of the residues in human CD4 critical for the binding of HIV. Cell 1989, 57:469-481.
16. Aubertin A-M, Wang Y, Le Grand R, Beyer C, Tao L, Neildez O, Barre-Sinoussi F, Hurtle B, Moog C, Lehner T, Girard M Generation of CD8-suppressor factor and β chemokines by targeted iliac lymph node immunization in monkeys challenged with SHIV-89. 6P by the rectal route. AIDS 2000, 16:381-392.
17. Baba TW, Trichel AM, An L, Liska V, Martin LN, Murphey Corb M, Ruprecht RM Infection and AIDS in adult macaques after nontraumatic oral exposure to cell-free SIV. Science 1996, 272:1486-1489.
18. Baba TW, Liska V, Hofmann-Lehmann R, Vlasak J, Xu W, Ayehunie S, Cavacini LA, Posner MR, Katinger H, Stiegler G, Bernacky BJ, Rizvi TA, Schmidt R, Hill LR, Keeling ME, Lu Y, Wright JE, Chou TC, Ruprect RM Human neutralising monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection. Nature Med. 2000, 6:200-206.
19. + monocytes. J. Immunol. Methods 2002, 264:1-10.
20. Belec L, Georges A, Steenman G, Martin P Antibodies to human immunodeficiency virus in vaginal secretions of heterosexual women. J. Infect. Dis. 1989, 160:385-391.
21. Belec L, Tevi-Benissan C, Gresenguet G, Meillet D, Pillot J HIV-1 antibody serum negativity with vaginal secretions positively. Lancet 1994, 343:1047-1048.
22. Belyakov IM, Hel Z, Kelsall B, Kuznetsov VA, Ahlers JD, Nacsa J, Watkins DI, Allen TM, Sette A, Altman J, Woodward R, Markham PD, Clements JD, Franchini G, Strober W, Berzofsky JA Mucosal AIDS vaccine reduces disease and viral load in gut reservoir and blood after mucosal infection of macaques. Nature Med. 2001, 7:1320-1326.
23. Berger R, Gartner S, Rappersberger K, Foster CA, Wolff K, Stingl G Isolation of human immunodeficiency virus type 1 from human epidermis: virus replication and transmission studies. J. Invest. Dermatol. 1992, 99:271.
24. Berger EA, Murphy PM, Farber JM Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism and disease. Annu. Rev. Immunol. 1999, 17:657-700.
25. Bergmeier LA, Mitchell EA, Hall G, Cranage MP, Cook N, Dennis M, Lehner T Antibody-secreting cells specific for simian immunodeficiency virus antigens in lymphoid and mucosal tissues of immunized macaques. AIDS 1998, 12:1139-1147.
26. Bergmeier LA, Wang Y, Lehner T The role of immunity in protection from mucosal SIV infection in macaques. Oral Dis. 2002, 8(suppl 2):63-68.
27. Berzofsky JA, Ahlers JD, Belyakov IM Strategies for designing and optimizing new generation vaccines. Nature 2001, 209-219.
28. Bhat S, Mettus RV, Reddy EP, Ugen KE, Srikanthan V, Williams WV, Weiner DB The galactosyl ceramide/sulfatide receptor binding region of HIV-1 gp120 maps to amino acids 206-275. AIDS Res. Hum. Retrovirol. 1993, 9:175-181.
29. Biberfeld P, Chayt KJ, Marselle LM, Biberfeld G, Gallo RC, Haper ME HTLVIII expression in infected lymph nodes and relevance to pathogenesis of lymphadenopathy. Am. J. Pathol. 1986, 125:436-442.
30. Biron CA, Nguyen KB, Pien GC, Cousens LP, Salazar-Mather TP Natural killer cells in antiviral defense: function and regulation by innate cytokines. Ann. Rev. Immunol. 1999, 17:189-200.
31. Bogers WMJM, Bergmeier LA, Ma J, Oostermeijer H, Wang Y, Kelly CG, Ten Haaft P, Singh M, Heeney JL, Lehner T A novel HIV-CCR5 receptor vaccine strategy in the control of mucosal SIV/HIV infection. AIDS 2004, 18:25-36.
32. Boullier S, Dadaglio G, Lafeuillade A, Debord T, Gougeon ML V delta 1 T cells expanded in the blood throughout HIV infection display a cytotoxic activity and are primed for TNF-alpha and IFN-gamma production but are not selected in lymph nodes. J. Immunol. 1987, 159:3629-3637.
33. Bourinbaiar AS, Phillips DM Transmission of human immunodeficiency virus from monocytes to epithelia. J. Acquir. Immun. Defic. Syndr. 1991, 4:56-63.
34. Bomsel M Transcytosis of infectious human immunodeficiency virus across a tight human epithelial cell barrier. Nat. Med. 1997, 3:42-47.
35. Bomsel M, Alfsen A Entry of viruses through the epithelial barrier: pathogenic trickery. Nature Rev. Mol. Cell Biol. 2003, 4:57-68.
36. Brookes R, Bergmeier LA, Mitchell E, Walker J, Tao L, Klavinskis L, Meyers NJ, Layton G, Adams SE, Lehner T Generation and diversity in the hierarchy of T cell epitope responses following different routes of immunization with simian immunodeficiency virus protein. AIDS 1995, 9:1017-1024.
37. Bukawa H, Sekigawa K-I, Hamajima K, Fukushima J, Yamada Y, Kiyono H, Okuda K Neutralization of HIV-1 by secretory IgA induced by oral immunization with a new macromolecular multicomponent peptide vaccine. Nat. Med. 1995, 1:681-685.
38. Camerini D, Seed B A CD4 domain important for HIV-mediated syncytium formation lies outside the virus binding site. Cell 1990, 60:747.
39. Cameron DW, Simonsen JN, D'Costa LJ, Ronald AR, Maitha GM, Gakinya MN, Cheang M, Ndinya-Achola JO, Piot P, Brunham, Plummer FA Female to male transmission of human immunodeficiency virus type 1: risk factors for seroversion in men. Lancet 1989, 2:403-407.
40. Capobianchi M, Ansel H, Amelglio F, Paganelli P, Pizzoli P, Dianzani F Recombinant glycoprotein 120 of human immunodeficiency virus is a potent interferon inducer. AIDS Res. Hum. Retroviruses 1992, 8:575-579.
41. Carmichael A, Jin X, Sissons P, Borysiewicz L Quantitation analysis of the human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T lymphocyte (CTL) response at different stages of HIV-1 infection: differential CTL responses to HIV-1 and Epstein Barr virus in late disease. J. Exp. Med. 1993, 177:249-256.
42. Chen Z, Zhou P, Ho DD, Landau NR, Marx PA Genetically divergent strains of simian immunodeficiency virus use CCR5 as a coreceptor for entry. J. Virol. 1997, 71:2705-2714.
43. Clements JD, Hartzog NM, Lyon FL Adjuvant activity of Escherichia coli heat labile enterotoxin and effect on the induction of oral tolerance in mice to unrelated protein antigens. Vaccine 1988, 6:269-277.
44. Clerici M, Shearer GM A Th1→Th2 switch is a critical step in the etiology of HIV infection. Immunol. Today 1993, 14:107-111.
45. Clerici M, Clark EA, Polacino P, Axberg I, Kuller LR, Caey NI, Morton WR, Shearer GM, Benveniste RE T-cell proliferation to subinfectious SIV correlates with lack of infection after challenge of macaques. AIDS 1994, 8:1391-1395.
46. + T cells. Science. 1995, 270:1811-1815.
47. Cranage MP, Baskerville A, Ashworth LAE, Dennis M, Cook N, Cook R, Sharpe SA, Rose J, Kitchin P, Greenaway PJ Mucosal infection and vaccine studies with macaque SIV. Vaccine. Res. 1992, 1:311-318.
48. Cranage MP, Baskerville A, Ashworth LAE, Dennis M, Cook N, Sharpe S, Farrar G, Rose J, Kitchin PA, Greenaway PJ Intrarectal challenge of macaques vaccinated with formalin-inactivated simian immunodeficiency virus. Lancet 1992, 339:273-274.
49. Cranage MP, Whatmore AM, Sharpe SA, Cook N, Polyanskaya N, Leech S, Smith JD, Rud EW, Dennis MJ, Hall GA Macaques infected with live attenuated SIVmac are protected against superinfection via the rectal mucosa. Virology 1997, 229:143-154.
50. + T lymphocytes by attenuated simian immunodeficiency virus. J. Virol. 2000, 74:8762-8766.
51. Curran JW, Morgan WM, Hardy AM, Jaffe HW, Darrow WW, Dowdle WR The epidemiology of AIDS: current status and future prospects. Science 1985, 229:1352-1357.
52. Dalgleish AG, Beverley PC, Clapham PR, Crawford DH, Greaves MF, Weiss RA The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature 1984, 312:763-767.
53. Deng H, Liu R, Ellmeier W, Choe S, Unutmaz D, Burkhart M, Marzio PD, Marmon S, Sutton RE, Hill CM, Davis CB, Peiper SC, Schall TJ, Littman DR, Landau NR Identification of a major co-receptor for primary isolates of HIV-1. Nature 1996, 381:661-666.
54. Deng H, Unutmaz D, KewalRamani VN, Littman DR Expression cloning of new receptors used by simian and human immunodeficiency viruses. Nature 1997, 388:296-300.
55. Detels R, Visschers B HIV and orogenital transmission. Lancet 1988, 2:1023.
56. Dossey DE HIV and orogenital transmission. Lancet 1988, 2:1023.
57. Dunn DT, Newell ML, Ades AE, Peckham C Risk of human immunodeficiency virus type 1 transmission through breastfeeding. Lancet 1992, 340:585-588.
58. + cells is mediated by the chemokine receptor CC-CKR-5. Nature 1996, 381:667-673.
59. Edinger AL, Adaemee A, Miller K, Doranz BJ, Endress M, Sharron M, Samson M, Lu Z-H, Clements JE, Murphey-Corb M, Peiper SC, Parmentier M, Broder CC, Doms RW Differential utilization of CCR5 by macrophage and T cell tropic simian immunodeficiency virus strains. Proc. Natl. Acad. Sci. USA 1997, 94:4005-4010.
60. Edinger AL, Mankowski JL, Doranz BJ, Marguilies BJ, Lee B, Rucker J, Sharron M, Hoffman TL, Berson JF, Zink MC CD4-independent CCR5-dependent infection brain capillary endothelial cells by a neurovirulent simian immunodeficiency virus strain. Proc. Natl. Acad. Sci. USA 1997, 94:14742-14747.
61. Embretson JE, Zupancic M, Ribas JL, Burke A, Racz P, Tenner-Racz K, Haase AT Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS. Nature 1993, 362:359-361.
62. Endreas MJ, Clapham PR, Marsh M, Ahuja M, Turner JD, McKnight A, Thomas JF, Stoebenau-Haggarty B, Choe S, Vance PJ, Wells TN, Power CA, Sutterwala SS, Doms RW, Landau NR, Hoxie JA CD4-independent infection by HIV-2 is mediated by fusin/CXCR4. Cell 1996, 87:745-756.
63. Eriksson K, Frederiksson M, Nordstrom I, Holmgren J Cholera toxin and its B subunit promoter dendritic cell vaccination with different influences on Th1 and Th2 development. Infect. Immun. 2003, 71:1740-1747.
64. Comparison of female to male and male to female transmission of HIV in 563 stable couples. BMJ 1992, 304:809. European study group on heterosexual transmission of HIV.
65. Farzan M, Choe H, Martin K, Marcon L, Hofman W, Karlsson G, Sun Y, Barrett P, Marcharnd N, Sullivan N, Gerard N, Gerard C, Sodroski J Two orphan seven-transmembrane segment receptors that are expressed in CD4 positive cells support simian immunodeficiency virus infection. J. Exp. Med. 1997, 186:405-411.
66. Fearon DT, Locksley RM The instructive role of innate immunity in the acquired immune response. Science 1996, 272:50-53.
67. Felman YM Recent developments in sexually transmitted diseases: Is heterosexual transmission of HIV a major epidemiologic factor in the spread of AIDS? New York City's experience. Sex. Transm. Dis. 1990, 46:29-31.
68. Feng Y, Broder CC, Kennedy PE, Berger EA HIV-1 entry cofactor: functional cDNA cloning of a seven transmembrane, G protein-coupled receptor. Science 1996, 272:872-877.
69. Finerty S, Stokes CR, Gruffydd-Jones TJ, Hillman TJ, Barr FJ, Harbour DA Targetted lymph node immunisation can protect cats from a mucosal challenge with feline immunodeficiency virus. Vaccine 2002, 20:49-58.
70. Francis ML, Meltzer Induction of IFN- α by HIV-1 in monocyte enriched PBMC requires gp120-CD4 interaction but not virus replication. J. Immunol. 1993, 151:2208-2216.
71. Frankel SS, Wenig BM, Burke AP, Mannan P, Thompson LD, Abbondanzo SL, Nelson AM, Pope M, Steinman RM Replication of HIV-1 in dendritic cell-derived syncytia at the mucosal surface of the adenoid. Science 1996, 272:115-117.
72. Fultz PN, McClure HM, Daugharty H, Brodie A, McGrath CR, Swenson B, Francis DP Vaginal transmission of human immunodeficiency virus (HIV). to a chimpanzee. J. Infect. Dis. 1986, 154:896-900.
73. Furuta Y, Eriksson K, Svennerholm B, Fredman P, Horal P, Jeansson S, Vahlne A, Holmgren J, Czerkinsky C Infection of vaginal and colonic epithelial cells by the human immunodeficiency virus type 1 is neutralized by antibodies raised against conserved epitopes in the envelope glycoprotein gp120. Proc. Natl. Acad. Sci. USA 1994, 91:12559-12563.
74. Geijtenbeek TBH, Torensma R, van Vilet SJ, van Duijnhoven GCF, Adema GJ, van Kooyk Y, Figdor CG Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptors that supports primary immune responses. Cell 2000, 100:575-585.
75. Geijtenbeek TBH, Kwon DS, Torensma R, van Viliet SJ, van Duijnhoven GCF, Middel J, Cornelissen ILMHA, Nottet HSLM, KewalRamani VN, Littman DR, Figdor CG, van Kooyk Y DC- SIGN, a dendritic cell-specific HIV-1 binding protein that enhances trans-infection of T cells. Cell 2000, 100:587-597.
76. George-Chandy A, Eriksson K, Lebans M, Nordstrom I, Schon E, Holmgren J Infect Immun 2001, 69:5716-5725.
77. Girard M, Fultz P, Barre-Sinoussi F, Muchmore E, Mahoney J, Rimsky L Further studies on HIV-1 vaccine protection in chimpanzees. Huitieme Colloque Des Cent Gardes 1993, 139-143. M. Girard, L. Velette (Eds.).
78. Granelli-Piperno A, Pope M, Inaba K, Steinman RM Co-expression of NFκ B/Rel and Sp1 transcription factors in human immunodeficiency virus 1-induced dendritic cell-T-cell syncytia. Proc. Natl. Acad. Sci. USA 1995, 92:10944-10948.
79. Gurunathan S, Klinman DM, Seder RA DNA vaccines: immunology, application and optimization. Ann. Rev. Immunol. 2000, 18:927-974.
80. Harandi AM, Eriksson K, Holmgren J A protective role of locally administered immunostimulatory CpG oligonucleotide in a mouse model of genital herpes infection. J. Virol. 2003, 77:953-962.
81. Harandi AM, Sanchez J, Eriksson K, Holmgren J Recent advances in mucosal immunomodulatory adjuvants. Curr. Opin. Invest. Drugs 2003, 4:156-161.
82. + cells from virus binding. J. Exp. Med. 1990, 172:1233-1242.
83. Heise C, Vogel P, Miller CJ, Halsted CH, Dandekar S Simian immunodeficiency virus infection of the gastrointestinal tract of rhesus macaques: Functional, pathological and morphological changes. Am. J. Pathol. 1993, 142:1759-1771.
84. Heise C, Miller CJ, Lackner A, Dandekar S Primary acute simian immunodeficiency virus infection of intestinal lymphoid tissue is associated with gastrointestinal dysfunction. J. Infect. Dis. 1994, 169:1116-1120.
85. Hill CM, Deng HK, Unutmaz D, Kewalramani VN, Bastiani L, Gorny MK, Zolla-Pazner S, Littman DR Envelope glycoproteins from HIV-1, HIV-2 and SIV can use human CCR5 as coreceptor for viral entry and make direct CD4-dependent interactions with this chemokine receptor. J. Virol. 1997, 71:6296-6304.
86. Hinz T, Wesch D, Friese K, Reckziegel A, Arden B, Kabelitz D T cell receptor gamma delta repertoire in HIV-1-infected individuals. Eur. J. Immunol. 1994, 24:3044-3049.
87. Ho DD, Neumann AU, Perelson AS, Chen W, Leonard JM, Markowitz M Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 1995, 373:123-126.
88. Hoffman TL, LaBranche CC, Zhang W, Gabriella C, Robinson J, Chaiken I, Hoxie JA, Doms RW Stable exposure of the coreceptor-binding site in a CD4-independent HIV-1 envelope protein. Proc. Natl. Acad. Sci. USA 1999, 96:6359-6364.
89. Hofmann-Lehman R, Vlasak J, Rasmussan RA, Jiang S, Li SL, Baba TW, Montifiori DC, Bernacky BJ, Rizvi TA, Schmidt R, Hill LR, Keeling ME, Katinger H, Stiegler G, Cavacini LA, Posner MR, Ruprecht RM Postnatal pre- and post exposure passive immunisation strategies: protection of neonatal macaques against oral simian-human immunodeficiency virus challenge. J. Med. Primatol. 2002, 31(3):109-119.
90. Homsy J, Meyer M, Tateno M, Clarkson S, Levy JA The Fc and not CD4 receptor mediates antibody enhancement of HIV infection in human cells. Science 1989, 244:1357-1360.
91. + T cells through IL-12 produced by Listeria-induced macrophages. Science 1993, 260:496-497.
92. Hu J, Gardner MB, Miller CJ Simian immunodeficiency virus rapidly penetrates the cervicovaginal mucosa after intravaginal inoculation and infects intraepithelial dendritic cells. J. Virol. 2000, 74:6087-6095.
93. Hussain LA, Kelly CG, Hecht E-M, Fellowes R, Jourdan M, Lehner T The expression of Fc receptors for immunoglobulin G in human rectal epithelium. AIDS 1991, 5:1089-1094.
94. Hussain LA, Kelly CG, Fellowes R, Hecht E-M, Wilson J, Chapman M, Lehner T Expression and gene transcript of Fc receptors for IgG, HLA class II antigens and Langerhans cells in human cervico-vaginal epithelium. Clin. Exp. Imm. 1992, 90:530-538.
95. Hussain LA, Lehner T Comparative investigation of Langerhans cells and potential receptors for HIV in oral, genitourinary and rectal epithelia. Immunology 1995, 85:475-484.
96. Izmailova E, Bertley FMN, Huang Q, Markori N, Miller CJ, Young RA, Aldovini A HIV-1 Tat reprogram immature dendritic cells to express chemoattractants from activated T cells and macrophages. Nature Med. 2003, 9:191-197.
97. Jakubik JJ, Saifuddin M, Takefman DM, Spear GT Immune complexes containing human immunodeficiency virus type 1 primary isolates bind to lymphoid tissue B lymphocytes and are infectious for T lymphocytes. J. Virol. 2000, 74552-74555.
98. Janoff EN, Jackson S, Wahl SM, Thomas K, Peterman JH, Smith PD Intestinal mucosal immunoglobulins during human immunodeficiency virus infection. J. Infect. Dis. 1994, 170:200-307.
99. Jarry A, Cortez A, Rene E, Muzeau F, Brousse N Infected cells and immune cells in the gastrointestinal tract of AIDS patients: an immunohistochemical study of 127 cases. Histopathology 1990, 16:133-140.
100. Kalter DC, Gendelman HE, Meltzer MS Infection of human epidermal Langerhans' cells by HIV. AIDS 1990, 4:266-268.
101. Kanitakis J, Marchand C, Su H, Thivolet J, Zambruno G, Schmitt D, Gazzolo L Immunohistochemical study of normal skin of HIV-1 infected patients shows no evidence of infection of epidermal Langerhans cells by HIV. AIDS Res. Hum. Retrovirol. 1989, 5:293-302.
102. Kawabata S, Miller CJ, Lehner T, Fujihashi K, Kubota M, McGhee JR, Imaoka K, Hiroi T, Kiyono H Induction of Th2 cytokine expression for p27-specific IgA B cell responses after targeted lymph node immunization with SIV antigens in rhesus macaques. J. Infect. Dis. 1998, 177:26-33.
103. Kim JJ, Nottingham LK, Sin JI, Tsai A, Morrison L, Dang K, Hu Y, Kazahaya K, Bennett M, Dentchev T, Wilson DM, Chalain AA, Boyer JD, Agadjanyan K, Weiner DB CD8 positive T cells influence antigen specific immune response through the expression of chemokines. J. Clin. Invest. 1998, 102:1112-1124.
104. Klatzmann D, Champagne E, Chamaret S, Gruest J, Guetard D, Hercend T, Glukman JC, Montagnier L T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV. Nature 1984, 312:767-768.
105. Klavinskis LS, Brookes R, Bergmeier LA, Mitchell E, Tao L, Lehner T Mucosal or targeted lymph node immunization of macaques with a particulate SIVp27 protein elicits virus-specific CTL in genito-rectal mucosa and draining lymph nodes. J. Immunol. 1996, 157:2521-2527.
106. Kreiss JK, Hopkins SG The association between circumcision status and human immunodeficiency virus infection among homosexual men. J. Infect. Dis. 1992, 168:1404-1408.
107. Kwong PD, Wyatt R, Robinson J, Sweet RW, Sodroski J, Hendrikson WA Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody. Nature 1998, 393:648-659.
108. Lehner T, Bergmeier LA, Panagiotidi C, Tao L, Brookes R, Klavinskis LS, Walker P, Walker J, Ward RG, Hussain L, Gearing AJH, Adams SE Induction of mucosal and systemic immunity to a recombinant simian immunodeficiency viral protein. Science 1992, 258:1365-1369.
109. Lehner T, Panagiotidi C, Bergmeier LA, Tao L, Brookes R, Adams SE A comparison of the immune responses following oral, vaginal or rectal route of immunization with SIV antigens in nonhuman primates. Vaccine Res. 1992, 1:319.
110. Lehner T, Brookes R, Panagiotidi C, Tao L, Bergmeier LA, Klavinskis LS, Walker P, Walker J, Ward RG, Hussain L, Gearing AJH, Adams SE T and B cell functions and ipitope expression in non-human primates immunized with SIV by the rectal route. Proc. Natl. Acad. Sci. USA 1993, 90:8638-8642.
111. Lehner T, Tao L, Panagiotidi C, Klavinskis LS, Brookes R, Hussain L, Meyers N, Adams SE, Gearing AJH, Bergmeier LA Mucosal model of genital immunization in male rhesus macaques with a recombinant simian immunodeficiency virus p27 antigen. J. Virol. 1994, 68:1624-1632.
112. Lehner T, Bergmeier LA, Tao L, Panagiotidi C, Klavinskis L, Hussain LA, Ward RG, Meyers N, Adams SE, Gearing AJH, Brookes R Targeted lymph node immunization with simian immunodeficiency virus p27 antigen to elicit genital, rectal and urinary immune responses in nonhuman primates. J. Immunol. 1994, 153:1858-1868.
113. Lehner T, Wang Y, Cranage M, Bergmeier LA, Mitchell E, Tao L, Hall G, Dennis M, Cook N, Brookes R, Klavinskis L, Jones I, Doyle C, Ward R Protective mucosal immunity elicited by targeted iliac lymph node immunisation with a subunit SIV envelope and core vaccine in macaques. Nature Med. 1996, 2:767-775.
114. Lehner T, Bergmeier L, Wang Y, Tao L, Mitchell E A rational basis for mucosal vaccination against HIV infection. Immunological Reviews 1999, 170:183-196.
115. Lehner T, Wang Y, Cranage M, Tao L, Mitchell E, Bravery C, Doyle C, Pratt K, Hall G, Dennis M, Villinger F, Bergmeier L Up-regulation of β chemokines and down modulation of CCR5 co-receptors inhibit simian immunodeficiency virus in nonhuman primates. Immunology 2000, 99:569-577.
116. Lehner T, Bergmeier LA, Wang Y, Tao L, Sing M, Spalleck R, van der Zee R Heat shock proteins generate β chemokines which function as innate adjuvants enhancing adaptive immunity. Eur. J. Immunol. 2000, 30:594-603.
117. Lehner T, Mitchell E, Bergmeier L, Singh M, Spallek R, Cranage M, Hall G, Dennis M, Villinger F, Wang Y The role of γδ T cells in generating antiviral factors and β chemokines in protection against mucosal simian immunodeficiency virus infection. Eur. J. Immunol. 2000, 30:2245-2256.
118. Levy JA Pathogenesis of human immunodeficiency virus infection. Microbiol. Rev. 1993, 57:183-289. (1993).
119. Li J, Lord CI, Haseltine W, Letvin NL, Sodroski J Infection of cynomolgus monkeys with a chimeric HIV-1/SIVmac virus that expresses the HIV-1 envelope glycoprotein. J. Acquir. Immune Defic. Syndr. 1992, 5:639-646.
120. Liao F, Alkhatib G, Pedan KW, Sharma G, Berger EA, Faber JM A novel chemokine receptor like protein, functions as a fusion cofactor for both macrophage tropic and T cell tropic HIV-1. J. Exp. Med. 1997, 185:2015-2023.
121. Lin C-L, Sewell AK, Gao GF, Whelan KY, Phillips RE, Austyn JM Macrophage-tropic HIV induces and exploits cell chemotaxis. J. Exp. Med. 2000, 192:587-593.
122. Lohman BL, Miller CJ, McChesney MB Antiviral cytotoxic T lymphocytes in vaginal mucosa of simian immunodeficiency virus-infected rhesus macaques. J. Immunol. 1995, 155:5855-5860.
123. Lu XS, Belec L, Pillot J Anti-gp160 IgG and IgA antibodies associated with a large increase in total IgG in cervicovaginal secretions from human immunodeficiency virus type 1 infected women. J. Infect. Dis. 1993, 167:1189-1192.
124. Lu Y, Brosio B, Lafaile M, Li J, Collman RG, Sodroski J, Miller CJ Vaginal transmission of chimeric simian/human immunodeficiency virus in rhesus macaques. J. Virol. 1996, 70:3045-3050.
125. Macatonia SE, Patterson ES, Knight SC Suppression of immune responses by dendritic cells infected with HIV. Immunology 1989, 67:285.
126. + cell anti-HIV activity: nonlytic suppression of virus replication. AIDS Res. Hum. Retroviruses 1992, 8:629-640.
127. + cell noncytotoxic anti-HIV response can be blocked by protease inhibitors. Proc. Natl. Acad. Sci. USA 2003, 100:3433-3438.
128. Maddon P, Molineaux SM, Maddon DE, Zimmerman KA, Godfrey M, Alt FW, Chess L, Axel R Structure and expression of the human and mouse T4 genes. Proc. Natl. Acad. Sci. USA 1987, 84:9155-9159.
129. Marthas M, Sutjipto S, Miller C, Higgins J, Torten J, Unger R, Kiyono H, McGhee J, Marx P, Pedersen N Efficacy of live-attenuated and whole-inactivated simian immunodeficiency virus vaccines against intravenous and intravaginal challenge. Vaccines 1992 1992, 117-122. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York. F. Brown, R.M. Chanock, H.S. Ginsberg, R.A. Lerner (Eds.).
130. Mascola JR, Steigler G, Vancott TC, Katinger H, Carpenter CB, Hanson CE, Beary H, Hayes D, Frankel SS, Birx DL, Lewis MG Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies. Nature Med. 2000, 6:207-210.
131. Mathewson JJ, Jiang ZD, DuPont HL, Chintu C, Luo N, Zumla A Intestinal secretory IgA immune response against human immunodeficiency virus among infected patients with acute and chronic diarrhea. J. Infect. Dis. 1994, 169:614-617.
132. Marx PA, Compans RW, Getie A, Staas JK, Gilley RM, Muligan MJ, Yamshchikov GV, Chen D, Eldridge JH Protection against vaginal SIV transmission with microencapsulated vaccine. Science 1993, 260:1323-1327.
133. Marx PA, Spira AI, Gettie A, Dailey PJ, Veazey RS, Lackner AA, Mahoney CJ, Miller CJ, Claypool LE, Ho DD, Alexander NJ Progesterone implants enhance SIV vaginal transmission and early virus load. Nat. Med. 1996, 2:1084-1089.
134. Mathijs JM, Hing M, Grierson J, Dwyer DE, Goldschmidt C, Cooper DA, Cunningham AL HIV infection of the rectal mucosa. Lancet 1988, 1:1111.
135. Mayer KH, Ayotte D, Groopman JE, Stoddard AM, Sarrgadharan M, Gallo R Association of human T lymphotropic virus type III antibodies with sexual and other behaviour in a cohort of homosexual men from Boston with and without generalised lymphadenopathy. Am. J. Med. 1986, 80:357.
136. Mazanec MB, Kaetzel CS, Lamm ME, Fletcher D, Nedrud JG Intracellular neutralization of virus by immunoglobulin A antibodies. Proc. Natl. Acad. Sci. USA 1992, 89:6901-6905.
137. McDermott MR, Bienenstock J Evidence for a common mucosal system. I. Migration of B immunoblasts into intestinal, respiratory and genital tissues. J. Immunol. 1979, 122:1892.
138. Medzhitov RM, Janeway CA Innate immunity: impact in immunology on the adaptive immune response. Curr. Opin. Immunol. 1997, 9:4-9.
139. McGhee JR, Czerkinsky C, Mestecky J Mucosal vaccines: an overview. Mucosal Immunology 1999, 741-757. Academic Press, New York. 2nd ed. P. Ogra, J. Mestecky, M.E. Lamm, W. Strober, J. Bienenstock, J.R. McGhee (Eds.).
140. + cells. Nature Med. 2002, 8:150-156.
141. Michalek SM, O'Hagan DT, Gould-Fogerite S, Zimmelzwaan GF, Osterhaus ADME Antigen delivery systems: non-living microparticles, liposomes, cochleates and ISCOMS. Mucosal Immunology 1999, 759-778. Academic Press, New York. 2nd ed. P.L. Ogra, J. Mestecky, M.E. Lamm, W. Strober, J. Bienenstock, J.R. McGhee (Eds.).
142. Miller CJ, Alexander NJ, Sutjipto S, Lackner AA, Hendrickx AG, Gettie A, Lowenstine LJ, Jennings M, Marx PA Genital mucosal transmission of simian immunodeficiency virus: Animal model for heterosexual transmission of human immunodeficiency virus. J. Virol. 1989, 63:4277-4284.
143. Miller CJ, Alexander NJ, Sutjipto S, Hendrickx AG, Jennings M, Marx PA Effect of virus dose and nonoxynol-9 on the genital transmission of SIV in rhesus macaques. J. Med. Primatol. 1990, 19:401-409.
144. Miller CJ, Alexander NJ, Vogel P, Anderson J, Marx PA Mechanism of genital transmission of SIV: A hypothesis based on transmission studies and the location of SIV in the genital tract of chronically infected female rhesus macaques. J. Med. Primatol. 1992, 21:64-68.
145. Miller CJ, Vogel P, Alexander NJ, Sutjipto S, Hendrickx AG, Marx PA Localization of SIV in the genital tract of chronically infected female rhesus macaques. Am. J. Pathol. 1992, 141:655-660.
146. Miller CJ, McChesney M, Moore PF Langerhans cells, macrophages and lymphocyte subsets in the cervix and vagina of rhesus macaques. Lab. Invest. 1992, 67:628-634.
147. Miller C, Kang D, Marthas M, Moldoveanu Z, Kiyono H, Marx P, Eldridge J, Mestecky J, McGhee J Genital secretory immune response to chronic SIV infection: a comparison between intravenously and genitally inoculated rhesus macaques. Clin. Exp. Immunol. 1992, 88:520-526.
148. Miller CJ, Vogel P, Alexander NJ, Dandekar S, Hendrickx AG, Marx PA Pathology and localisation of SIV in the reproductive tract of chronically infected male rhesus macaques. Lab. Invest. 1994, 70:255-262.
149. Miller CJ, Marthas M, Torten J, Alexander NJ, Moore JP, Doncel GF, Hendrickx AG Intravaginal inoculation of rhesus macaques with cell free simian immunodeficiency virus results in persistent or transient viremia. J. Virol. 1994, 68:6391-6400.
150. Milone MC, Fitzgerald-Bocarsly P The mannose receptor mediates induction of IFNα in peripheral blood dendritic cells by enveloped RNA and DNA viruses. J. Immunol. 1998, 161:2391-2399.
151. Mitchell EA, Bergmeier LA, Doyle C, Brookes R, Hussain LA, Wang Y, Lehner T Homing of mononuclear cells from the iliac lymph node to the genital and rectal mucosa in non-human primates. Eur. J. Immunol. 1998, 28:3066-3074.
152. Moir S, Malaspina A, Li Y, Chun T-W, Lowe T, Adelsberger J, Baseler M, Ehler LA, Liu S, Davey RT, Mican JAM, Fauci AS B cells of HIV-1-infected patients bind virions through CD21-complement interactions and transmit infectious virus to activated T cells. J. Exp. Med. 2000, 192:637-643.
153. Mohamed OA, Ashley R, Goldstein A, McElrath J, Dalessio J, Corey L Detection of rectal antibodies to HIV-1 by a sensitive chemiluminescent western blot immunodetection method. J. Acquir. Immune. Defic. Syndr. 1994, 7:375-380.
154. Moore JP, Binley J Envelopes letters boxed into shape. Nature 1998, 393:630-631.
155. Moretta L, Biassoni R, Bottino C, Mingari MC, Moretta A Human NK-cell receptors. Immunol. Today 2000, 21:420-422.
156. Musey L, Hu Y, Eckert L, Christensen M, Karchmer T, McElrath MJ HIV-1 induces cytotoxic T lymphocytes in the cervix of infected women. J. Exp. Med. 1997, 185:293-303.
157. Muster T, Steindl F, Purtscher M, Trkola A, Kilma A, Himmler G, Ruker F, Katinger H A conserved neutralizing epitope on gp41 of human immunodeficiency virus type 1. J. Virol. 1993, 67:6642-6647.
158. Nelson JA, Wiley CA, Reynolds-Kohler C, Reese CE, Margaretten W, Levy J Human immunodeficiency virus detected in bowel epithelium from patients with gastrointestinal symptoms. Lancet 1988, 1:259-262.
159. Nixon DF, Townsend ARM, Elvin JG, Rizza CR, Gallwey J, McMichael AJ HIV-1 gag specific cytotoxic T lymphocytes defined with recombinant vaccinia virus and synthetic peptides. Nature 1988, 336:484-487.
160. Nuovo GJ, Forde A, MacConnell P, Farenwald R In situ detection of PCR-amplified HIV-1 nucleic acids and tumor necrosis factor cDNA in cervical tissues. Am. J. Pathol. 1993, 143:40-48.
161. Ohshiro Y, Murakami T, Matsudo K, Nishioka K, Yoshida K, Yamamoto N Role of a cell surface glycosaminoglycans of human T cells in immunodeficiency virus type-1 (HIV-1) infection. Microbial Immunol. 1996, 40:827-835.
162. O'Leary AD, Sweeny EC Lymphoglandular complexes of the colon: structure and distribution. Histopathology 1986, 10:267-283.
163. Ostrowski MA, Justement SJ, Catanzaro A, Hallahan CA, Ehler LA, Mizell SB, Kumar PN, Mican JA, Chun T-W, Fauci AS Expression of chemokine receptors CXCR4 and CCR5 in HIV-1-infected and uninfected individuals. J. Immunol. 1998, 161:3195-3201.
164. Owen RL, Nemanic P Antigen processing structures of the mammalian intestinal tract: an SEM study of lymphoepithelial organs. Scanning Electron Microsc. 1978, 2:367-378.
165. Pang S, Shlesinger Y, Daar ES, Mondgil T, Ho DD, Chen IS Rapid generation of sequence variation during primary HIV-1 infection [erratum appears in AIDS 1992 Jun 6(6), following 606]. AIDS 1992, 6:453-460.
166. Pantaleo G, Graziosi C, Demarest JF, Butini L, Montroni M, Fox CH, Orenstein JM, Kotler DP, Fauci AS HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature 1993, 362:355-357.
167. Patel M, Yanagishita M, Roderiquez G, Bou-Habib DC, Oravecz T, Hascall VC, Norcross MA AIDS Res. Hum. Retroviruses 1993, 9:167-174.
168. Patterson BK, Landay A, Andersson J, Brown C, Behbahani H, Jiyamapa D, Burki Z, Stanislawski D, Czerniewski MA, Garcia P Repertoire of chemokine receptor expression in the female genital tract. Am J. Pathol. 1998, 153:481-490.
169. Pauza CD, Malkovsky M, Salvcata MS SIV transmission across the mucosal barrier. AIDS Res. Hum. Retroviruses 1994, 10:7-10.
170. Peterson A, Seed B Genetic analysis of monoclonal antibody and HIV binding sites on the human lymphocyte antigen CD4. Cell 1988, 54:65.
171. Pomerantz RJ, de la Monte SM, Donegan CE, Rota TR, Vogt MW, Craven DE, Hirsch MS Human immunodeficiency virus (HIV) infection of the uterine cervix. Ann. Intern. Med. 1988, 108:321-327.
172. Pontow SE, Kery V, Stahl PD Mannose receptor. Int. Rev. Cytol. B 1992, 137:221-244.
173. Pope M, Betjes MG, Romani N, Hirmand H, Cameron PU, Hoffman L, Pope S, Gezelter S, Schuler G, Steinman RM Conjugates of dendritic cells and memory T lymphocytes from skin facilitate productive infection with HIV-1. Cell 1994, 78:389.
174. Putkonen P, Nilsson C, Makitalo B, Biberfeld G, Thorstensson R, Cranage M, Rud F Immunization with live attenuated SIVmac can protect macaques against mucosal infection with SIVsm. Vaccines 96 1996, 235-241. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York.
175. Rasmussen RA, Hoffmann-Lehmann R, Montefiore DC, Li P-L, Liska V, Vlasak J, Baba TW, Schmitz JE, Kuroda MJ, Robinson HL, McClure HM, Lu S, Hu S-L, Rizvi TA, Ruprecht RM DNA prime/protein vaccine strategy in neonatal macaques against simian human immunodeficiency virus. J. Med. Primatol. 2002, 31:40-60.
176. Ravetch JV, Lanier LL Immune inhibitory receptors. Science 2000, 290:84-89.
177. Reeves JD, McKnight A, Potempa S, Simmons G, Gray PW, Power CA, Wells T, Weiss RA, Talbot SJ CD4-independent infection by HIV-2 (ROD/B): use of the 7-transmembrane receptors CXCR4, CCR3 and V28 for entry. Virology 1997, 231:130-134.
178. Reimann KA, Tenner-Racz K, Racz P, Montefiori DC, Yasutomi Y, Lin W, Ransil BJ, Letvin NL Immunopathogenic events in the acute infection of rhesus monkeys with simian immunodeficiency virus of macaques. J. Virol. 1994, 68:2362-2370.
179. Rescigno M, Urbano M, Valzasina B, Franconi M, Rotta G, Bonasio R, Granucci F, Kraehenbuhl JP, Ricciardi-Castagnoli P Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria. Nature Immunol. 2001, 2:288-290.
180. Roderiquez G, Oravecz T, Yanagishita M, Bou-Habib DC, Mostowski H, Norcross MA Mediation of human immunodeficiency virus type 1 binding by interaction of cell surface heparin sulphate proteoglycans with the V3 region of envelope gp120-gp41. J. Virol. 1995, 69:2233-2239.
181. Rugeles MT, Trubey CM, Bedoya VI, Pinto LA, Oppenheim JJ, Rybak SM, Shearer GM Ribonuclease is partly responsible for the HIV-1 inhibitory effect activated by HLA alloantigen recognition. AIDS 2003, 17:481-486.
182. Ruprecht RM, Baba TW, Liska V, Ray NB, Martin LN, Murphey-Corb M, Risvu TA, Bernacky BJ, Keeling ME, McClure HM, Andersen J Oral transmission of primate lentiviruses. J. Infect. Dis. 1999, 179(suppl 3):S408-S412.
183. Sallusto F, Lenig D, Mackay CR, Lanzavecchia A Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes. J. Exp. Med. 1998, 187:875-883.
184. Sallusto F, Schaerli P, Loetscher P, Schaniel C, Lenig D, Mackay CR, Qin S, Lanzavecchia A Rapid and coordinated switch in chemokine receptor expression during dendritic cell maturation. Eur. J. Immunol. 1998, 28:2760-2769.
185. Sallusto F, Lanzavecchia A, Mackay CR Chemokines and chemokine receptors in T-cell priming and Th1/Th2-mediated responses. Immunol. Today 1998, 19:568-574.
186. Sallusto F, Palermo B, Lenig D, Meittinen M, Matikainen S, Julkunen I, Forster R, Brugstahler R, Lipp M, Lanzavecchia M Distinct patterns and kinetics of chemokine production regulate dendritic cell function. Eur. J. Immunol. 1999, 29:1617-1625.
187. Sallusto F, Mackay CR, Lanzavecchia M The role of chemokine receptors in primary, effector and memory immune responses. Ann. Rev. Immunol. 2000, 18:593-620.
188. Samuel MC, Hessol N, Shiboski S, Engel RR, Speed TP, Winkelstein W Factors associated with human immunodeficiency virus seroconversion in homosexual men in three San Francisco cohort studies. J. AIDS 1993, 6:303-312.
189. Schacker T, Collier AC, Hughes J, Shea T, Corey L Clinical and epidemiologic features of primary HIV infection. Ann. Intern. Med. 1996, 125:257-264.
190. Schafer F, Kewenig S, Stolte N, Stahl-Hennig C, Stallmach A, Kaup FJ, Zeitz M, Schneider T Lack of simian immunodeficiency virus (SIV) specific IgA response in the intestine of SIV infection rhesus macaques. Gut 2002, 50:608-615.
191. Simonsen JN, Cameron DW, Gakinya MN, Ndinya-Achola JO, O'Costa LJ, Karasira P, Cheang M, Ronald AR, Piot P, Plummer FA Human immunodeficiency virus infection among men with sexually transmitted diseases: experience from a center in Africa. N. Engl. J. Med. 1988, 319:274-278.
192. Soto-Ramirez LE, Renjifo B, McLane MF, Marlink R, O'Hara C, Sutthent R, Wasi C, Vithayasai P, Vithayasai V, Apichartpiyakul C, Auewarakul P, Cruz VP, Chu D-S, Osathanondh R, Mayer K, Lee T-H, Essex M HIV Langerhans' cell tropism associated with heterosexual transmission of HIV. Science 1996, 271:1291-1293.
193. Spira AI, Marx PA, Patterson BK, Mahoney J, Koup RA, Wolinsky SM, Ho DD Cellular targets of infection and route of viral dissemination after an intravaginal inoculation of simian immunodeficiency into rhesus macaques. J. Exp. Med. 1996, 183:215-225.
194. Spear GT, Sha BE, Saarloos MN, Benson CA, Rydman R, Massad LS, Gilmore R, Landay AL Chemokines are present in the genital tract of HIV-seropositive and HIV-seronegative women. J. Acquir. Immun. Defic. Syndr. Human Retrovirol. 1998, 18:454-459.
195. + T-cell response. J. Virol. 2002, 76:688-696.
196. Takahashi I, Marinaro M, Kiyono H, Jackson RJ, Nakagawa I, Fujihashi K, Hamada S, Clements JD, Bost KL, McGhee JR Mechanisms for mucosal immunogenicity and adjuvanticity of Escherichia coli labile enterotoxin. J. Infect. Dis. 1996, 173:627-635.
197. Takeda A, Tuazon CU, Ennis FA Antibody-enhanced infection by HIV-1 via Fc receptor-mediated entry. Science 1988, 242:580-583.
198. Tenner-Racz K, Racz P, Bofil M, Schultz-Meyer A, Dietrich M, Kern P, Weber J, Pinching AJ, Veronese-DiMarzo F, Popovic M, Klatzmann D, Gluckman JC, Janossey G Htlv-III/LAV viral antigens in lymph nodes of homosexual men with persistent generalised lymphadenopathy and AIDS. Am. J. Pathol. 1986, 123:9-15.
199. Trivedi P, Meyer KK, Streblow DN, Preuinger BL, Schultz KT, Pauza CD Selective amplification of simian immunodeficiency virus genotypes after intrarectal inoculation of rhesus monkeys. J. Virol. 1994, 68:7649-7653.
200. Trkola A, Pomales AB, Yuan H, Korber B, Maddon PJ, Allaway GP, Katinger H, Barbas CF, Burton DR, Ho DD, Moore JP Cross-clade neutralisation of primary isolates of human immunodeficiency virus type 1 by human monoclonal antibodies and tetrameric CD4-IgG. J. Virol. 1995, 69:6609-6617.
201. Tschachler E, Groh V, Popvic M, Mann DL, Konrad K, Safai B, Eron L, diMarzo-Veronese F, Wolff K, Stingl G Epidermal Langerhans cells: a target for HTLV-III/LAV infection. J. Invest. Dermatol. 1987, 88:233-237.
202. Ugolini S, Mondor I, Sattentau QJ HIV-1 attachment: another look. Trends Microbiol. 1999, 7:144-149.
203. UNAIDS, WHO AIDS Epidemic Update: December 2001 2001, (accessed online at http://www.unaids.org, June 25, 2002)., UNAIDS, Geneva.
204. van de Perre P, Simonon A, Hitimana D-G, Dabis F, Msellati P, Mukamabano B, Butera J-B, van Goethem C, Karita E, Lepage P Infective and anti-infective properties of breastmilk from HIV-1 infected women. Lancet 1993, 341:914-918.
205. van der Berg LH, Sadiq S, Lederman S, Latov N The gp120 glycoprotein of HIV-1 binds to sulfatide and to the myelin associated glycoprotein. J. Neurosci. Res. 1992, 33:513-518.
206. Veazey RS, Shattock RJ, Pope M, Kirijan C, Jones J, Hu Q, Ketas T, Marx PA, Klasse P-J, Burton DR, Moore J Prevention of virus transmission to macaque monkeys by a vaginally applied monoclonal antibody to HIV-1 gp120. Nature Med 2003, 9:343-346.
207. Wakrim L, LeGrand R, Vaslin B, Cheret A, Matheux F, Theodoro F, Roques P, Nicol-Jourdain I, Dormont D Superinfection of HIV-2 preinfected macaques after rectal exposure to a primary isolate of SIVmac251. Virology 1996, 221:260-270.
208. Wallace M, Bartz SR, Chang W-L, MacKenzie D, Pauza CD, Malkovsky M γδ T lymphocyte responses to human immuno-deficiency virus. Clin. Exp. Immunol. 1996, 103:177-184.
209. Walker BD, Chakrabarti S, Moss B, Paradis TJ, Flynn T, Durno AG, Blumberg R, Kaplan JC, Hirsch MS, Scholley HIV-specific cytotoxic T lymphocytes in seropositive individuals. Nature 1987, 328:345-348.
210. + lymphocytes can control HIV infection in vitro by suppressing virus replication. Science 1986, 234:1563-1566.
211. Wang Y, Tao L, Mitchell E, Bogers WMJ, Doyle C, Bravery CA, Bergmeier LA, Kelly CG, Heeney JL, Lehner T Generation of CD8 suppressor factor and β chemokines, induced by xenoimmunisation, in the prevention of simian immunodeficiency virus infection. Proc. Natl. Acad. Sci. USA 1998, 95:5223-5228.
212. + T cell chemokines, HIV suppressor factors and resistance to HIV infection in women. Nature Med. 1999, 5:1004-1009.
213. Wang Y, Kelly CG, Karttunen JT, Whittall T, Lehner PJ, Duncan L, MacAry P, Younson JS, Singh M, Oehlmann W, Cheng G, Bergmeier L, Lehner T CD40 is a cellular receptor mediating mycobacterial heat shock protein 70 stimulation of CC chemokines. Immunity 2001, 15:971-983.
214. Wang Y, Kelly CG, Singh M, McGowan EG, Carrara A-S, Bergmeier LA, Lehner T Stimulation of Th1-polarazing cytokines, C-C chemokines, maturation of dendritic cells, and adjuvant function by the peptide binding fragment of heat shock protein 70. J. Immunol. 2002, 169:2422-2429.
215. Wei X, Ghosh SK, Tayleor ME, Johnson VA, Emini EA, Deutsch P, Lifson JD, Bonheoffer S, Nowak MA, Hahn BH, Saag MS, Shaw GM Viral dynamics in human immunodeficiency virus type-1 infection. Nature 1995, 373:117.
216. Weissman D, Li Y, Orenstein JM, Fauci AS Both a precursor and a mature population of normal human dendritic cells can bind HIV. J. Immunol. 1995, 155:4111-4117.
217. Winkelstein W, Wiley JA, Padian N, Levy J Potential for transmission of AIDS-associated retrovirus from bisexual men in San Francisco to their female sexual contacts. JAMA 1986, 255:901.
218. Winkelstein W, Lyman DM, Padian N, Grant R, Samuel M, Wiley JA, Anderson RE, Lang W, Riggs J, Levy JA Sexual practices and risk of infection by the human immunodeficiency virus. The San Francisco Men's Health Study. JAMA 1987, 257:321-325.
219. Wira CR, Sandoe CP Specific IgA and IgG antibodies in the secretions of the female reproductive tract: effects of immunization and estradiol on expression of this response in vivo. J. Immunol. 1987, 138:4159-4164.
220. Wira CR, Sandloe CP Effect of uterine immunization and oestradiol on specific IgA and IgG antibodies in uterine vaginal and salivary secretions. Immunology 1989, 68:24-30.
221. Wolff H, Mayer K, Seage G, Politch J, Horsburgh CR, Anderson DJ A comparison of HIV-1 antibody classes, titers and specificities in paired semen and blood samples from HIV-1 seropositive men. J. AIDS 1992, 5:65-69.
222. Yahi N, Baghdiguian S, Moreau H, Fantini J Galactosyl ceramide (or a closely related molecule). is the receptor for human immunodeficiency virus type 1 on human colon epithelial HT29 cells. J. Virol. 1992, 66:4848-4854.
223. + lymphocyte response in acutely infected rhesus monkeys. J. Virol. 1993, 67:1707-1711.
224. Zaitseva M, Blauvelt A, Lee S, Lapham C, Klaus-Kovtun V, Mostowski H, Manischewitz, Golding H Expression and function of CCR5 and CXCR4 on human Langerhans cells and macrophages: implications for HIV primary infection. Nature Med. 1997, 3:1369-1375.
225. Zhang LQ, MacKenzie P, Cleland A, Holmes EC, Leigh Brown AJ, Simmonds P Selection for specific sequences in the external envelope protein of human immunodeficiency virus type 1 upon primary infection. J. Virol. 1993, 67:3345-3356.
226. Zhang L, Yu W, He T, Yu J, Caffrey RE, Dalmasso EA, Fu S, Pham T, Mei J, Ho JJ, Zhang W, Lopez P, Ho DD Contribution of human α-defensins 1, -2, and -3 to the anti HIV-1 activity of CD8 antiviral factor. Science 2002, 298:995-1000.
227. Zhu T, Mo H, Wang N, Nam DS, Cao Y, Koup RA, Ho DD Genotypic and phenotypic characterization of HIV-1 patients with primary infection. Science 1993, 261:1179-1181.